What’s Next for Health Policy in 2026? Part 2: An Outlook for the Biopharmaceutical Industry: CMS and FDA?

This program is part two of Manatt’s What’s Next for Health Policy in 2026? webinar series.

2025 was a year marked by seismic shifts in the health policy landscape. With 2025 in the rearview mirror, 2026 will be the year when many of these major changes are implemented – with more changes on the horizon.

Learn the Manatt life sciences team’s public policy outlook for 2026:

• What elements of international reference pricing will take hold?
• How will Medicaid funding cuts put pressure on patient access to treatment?
• Which FDA medical product review areas will be impacted by operational and policy shifts?
• What factors will drive adoption of coverage for anti-obesity medicine in Medicare and Medicaid?

This two-part webinar series will explore anticipated actions and provide insight on additional areas for potential policymaking in 2026. While many of these policy changes are crosscutting, our discussion will be divided into two parts: The first will focus on Medicaid, the Marketplaces, Medicare, and public health; the second will focus on prescription drugs and the life sciences industry.

Speakers

• , Partner, Manatt Health
• , Partner, Manatt Health
• , Partner, Manatt Health
• , Partner, Manatt Health

Date and Time:

Wednesday, February 11
2:00 p.m. – 3:00 p.m. ET
11:00 a.m. – 12:00 p.m. PT